Kawanishi H, Harada Y, Sakikubo E, Moriishi M, Nagai T, Tsuchiya S
Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan.
Adv Perit Dial. 2000;16:252-6.
Sclerosing encapsulating peritonitis (SEP) is recognized as a serious complication of continuous ambulatory peritoneal dialysis (CAPD). To date, in our hospital, 12 cases of SEP have been successfully treated by active intervention. The development of SEP was observed in these patients after removal of a peritoneal catheter. SEP was relieved by steroid administration in 3 of these patients, and by total parenteral nutrition (TPN) performed after exploratory laparotomy in 1 patient. In the remaining 8 patients, SEP was relieved by total intestinal enterolysis. In patients who underwent total intestinal enterolysis, the severity of encapsulation and adhesion varied. White, rigid encapsulation was observed in 4 patients who had been treated by peritoneal dialysis (PD) for less than 10 years. Seemingly normal serosae were observed under the capsules, and total intestinal enterolysis was easily performed in these patients. In the patient who underwent renal transplantation, more severe intestinal adhesion was observed, although the duration of PD was limited to 70 months and the intestinal serosae were seemingly normal. These findings were considered specific to SEP developing after immunosuppressant administration. In 3 patients who had undergone PD for more than 10 years, degeneration of the visceral peritoneum was observed, together with an ill-defined boundary between the capsules and the serosae. Therefore, total enterolysis was performed in these patients, including a wide area of the muscular layer. Furthermore, calcification was observed in several regions, where the capsules were severely adherent to the parietal peritoneum. The post-operative course for all 8 patients was satisfactory, and these patients finally returned to their previous social activities. We conclude that when SEP symptoms are not improved by steroid administration or TPN, active total intestinal enterolysis should be performed. However, it is absolutely important to avoid inducing anastomosis or impairing the intestine.
硬化性包裹性腹膜炎(SEP)被认为是持续性非卧床腹膜透析(CAPD)的一种严重并发症。迄今为止,在我院,12例SEP患者通过积极干预已成功治愈。这些患者在拔除腹膜导管后出现了SEP。其中3例患者通过使用类固醇缓解了SEP,1例患者在剖腹探查术后通过全胃肠外营养(TPN)缓解了SEP。其余8例患者通过全肠松解术缓解了SEP。在接受全肠松解术的患者中,包裹和粘连的严重程度各不相同。4例接受腹膜透析(PD)少于10年的患者观察到白色、坚硬的包裹。在包膜下观察到看似正常的浆膜,这些患者易于进行全肠松解术。在接受肾移植的患者中,尽管PD时间限于70个月且肠浆膜看似正常,但观察到更严重的肠粘连。这些发现被认为是免疫抑制剂给药后发生SEP的特异性表现。3例接受PD超过10年的患者,观察到脏腹膜退变,包膜与浆膜之间界限不清。因此,对这些患者进行了全肠松解术,包括广泛的肌层。此外,在几个区域观察到钙化,包膜与壁腹膜严重粘连。所有8例患者的术后过程均令人满意,这些患者最终恢复了以前的社交活动。我们得出结论,当SEP症状通过类固醇给药或TPN未改善时,应积极进行全肠松解术。然而,避免引起吻合口或损伤肠道绝对重要。